Your browser doesn't support javascript.
loading
Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.
Aptsiauri, Natalia; Jewett, Anahid; Hurwitz, Arthur A; Shurin, Michael R; Umansky, Viktor.
Afiliação
  • Aptsiauri N; Department of Clinical Analysis and Immunology, UGC Clinical Laboratory, Institute of Biosanitary Research ibs.Granada, University of Granada Hospital Complex, Granada, Spain.
  • Jewett A; Tumor Immunology Laboratory, Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, UCLA School of Dentistry, Los Angeles, CA, USA.
  • Hurwitz AA; Agenus Inc., Lexington, MA, USA.
  • Shurin MR; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. v.umansky@dkfz.de.
Cancer Immunol Immunother ; 65(7): 875-83, 2016 07.
Article em En | MEDLINE | ID: mdl-26810566
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article